Ardelyx (ARDX) Total Debt (2018 - 2026)
Ardelyx (ARDX) reported Total Debt of $203.5 million for Q1 2026, up 34.51% on a YoY basis from $151.3 million in Q1 2025, and little changed quarter-over-quarter from $202.8 million in Q4 2025.
Ardelyx (ARDX) Total Debt (2018 - 2026) Analysis & Trends
Ardelyx has reported Total Debt for 9 years, with the latest figure at $203.5 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt rose 34.51% year-over-year to $203.5 million; the trailing twelve-month figure through Mar 2026 stood at $203.5 million (up 34.51% YoY), and the FY2025 full-year result was $202.8 million, up 34.46% from the prior year.
- Total Debt for Q1 2026 stood at $203.5 million, roughly flat from $202.8 million in the prior quarter.
- The five-year high for Total Debt was $203.5 million in Q1 2026, with the low at $26.1 million in Q1 2022.
- Historically, Total Debt has averaged $97.0 million across 5 years, with a median of $99.8 million in 2024.
- Annual changes were most pronounced in 2022 — Total Debt slumped 48.76% — and 2024, when it soared 271.41%.
- Ardelyx's Total Debt stood at $26.7 million in 2022, then jumped by 86.52% to $49.8 million in 2023, then soared by 202.78% to $150.9 million in 2024, then soared by 34.46% to $202.8 million in 2025, then grew by 0.34% to $203.5 million in 2026.
- The last three Total Debt figures came in at $203.5 million (Q1 2026), $202.8 million (Q4 2025), and $202.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 203.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203.52 Mn |
| Dec 31, 2025 | 202.83 Mn |
| Sep 30, 2025 | 202.14 Mn |
| Jun 30, 2025 | 201.45 Mn |
| Mar 31, 2025 | 151.30 Mn |
| Dec 31, 2024 | 150.85 Mn |
| Sep 30, 2024 | 100.71 Mn |
| Jun 30, 2024 | 100.25 Mn |
| Mar 31, 2024 | 99.83 Mn |
| Dec 31, 2023 | 49.82 Mn |
| Sep 30, 2023 | 27.23 Mn |
| Jun 30, 2023 | 27.05 Mn |
| Mar 31, 2023 | 26.88 Mn |
| Dec 31, 2022 | 26.71 Mn |
| Sep 30, 2022 | 26.54 Mn |
| Jun 30, 2022 | 26.37 Mn |
| Mar 31, 2022 | 26.14 Mn |
| Dec 31, 2021 | 32.26 Mn |
| Sep 30, 2021 | 51.48 Mn |
| Jun 30, 2021 | 51.24 Mn |